Star Source Multi Trade share news and announcements

BSE: 506365Pharmaceuticals & BiotechnologySmall Cap

₹105.66₹2.64 (2.44%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹108.30.

52-week range of traded prices to 23 Oct 2026

₹70.01Low, 17 Sep 2026₹152.90High, 2 Jan 2026

Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.

Market cap: ₹16 Cr4,271st largest listed
P/E: Lossover the last 12 months
P/B: 12.3
Dividend yield: Nonein the last 12 months
ROE: −0.5%
ROCE: −3.1%
Debt to equity: 0.00
Volume, BSE: 1,049

Star Source Multi Trade board meetings

123 filed, newest first. Page 1 of 3.

Sep 2026
- 1 Sep · Board meeting
  Outcome of Board Meeting held on September 01,. 2026 (opens in a new tab)
Aug 2026
- 27 Aug · Board meeting
  Meeting on 1 Sep 2026: annual general meeting
- 27 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 01/09/2026 ,inter alia, to consider and approve Board Meeting on September .... (opens in a new tab)
- 11 Aug · Board meeting
  Meeting on 14 Aug 2026: quarterly results
- 11 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve un-audited financial .... (opens in a new tab)
May 2026
- 25 May · Board meeting
  Meeting on 29 May 2026: audited results and quarterly results
- 25 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial .... (opens in a new tab)
Feb 2026
- 16 Feb · Board meeting
  Revised Outcome of Board Meeting held on February 12, 2026. (Correction in typo of outcome Time). Correct time is 12:45 PM. (opens in a new tab)
- 9 Feb · Board meeting
  Meeting on 12 Feb 2026: quarterly results
- 9 Feb · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the Un-Audited Financial .... (opens in a new tab)
Nov 2025
- 10 Nov · Board meeting
  Meeting on 13 Nov 2025: quarterly results
- 10 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve unaudited financial .... (opens in a new tab)
Aug 2025
- 22 Aug · Board meeting
  Board approved Reclassification request received to change the status from Promoter Group Shareholder to Public Shareholder (opens in a new tab)
- 14 Aug · Board meeting
  Meeting on 22 Aug 2025
- 14 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 22/08/2025 ,inter alia, to consider and approve the request letter .... (opens in a new tab)
- 5 Aug · Board meeting
  Meeting on 12 Aug 2025: annual general meeting and quarterly results
- 5 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve the following business: 1. .... (opens in a new tab)
Jul 2025
- 31 Jul · Board meeting
  Outcome of Board Meeting. INTIMATION OF APPOINTMENT OF STATUTORY AUDITOR. 1. Resignation of Statutory Auditor: The Board of Directors noted and accepted the resignation of M/s Sanjay .... (opens in a new tab)
- 28 Jul · Board meeting
  Meeting on 31 Jul 2025
- 28 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider and approve 1. To consider and .... (opens in a new tab)
May 2025
- 29 May · Board meeting
  Outcome of Board Meeting held on May 29, 2025 (opens in a new tab)
- 14 May · Board meeting
  Meeting on 29 May 2025: audited results
- 14 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve the Audited Financial .... (opens in a new tab)
- 2 May · Board meeting
  Meeting on 2 May 2025
- 2 May · Board meeting
  Outcome of Board Meeting Held on Friday, May 02, 2025 (opens in a new tab)
Apr 2025
- 16 Apr · Board meeting
  OUTCOME OF THE BOARD MEETING HELD ON WEDNESDAY, APRIL 16, 2025 (opens in a new tab)
- 8 Apr · Board meeting
  Meeting on 16 Apr 2025
- 8 Apr · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 16/04/2025 ,inter alia, to consider and approve Appointment of Directors .... (opens in a new tab)
Jan 2025
- 13 Jan · Board meeting
  Meeting on 27 Jan 2025: quarterly results
- 13 Jan · Board meeting
  CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 ,inter alia, to consider and approve the following businesses:- .... (opens in a new tab)
Oct 2024
- 15 Oct · Board meeting
  Meeting on 28 Oct 2024: quarterly results
- 15 Oct · Board meeting
  CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 ,inter alia, to consider and approve the Un-Audited Financial .... (opens in a new tab)
Jul 2024
- 29 Jul · Board meeting
  1. Approval of Un-Audited Financial Results of the Company for the quarter ended June 30, 2024 along with the Limited Review Report thereon. 2. Approval of the Notice of the 82nd Annual .... (opens in a new tab)
- 9 Jul · Board meeting
  Meeting on 29 Jul 2024: annual general meeting and quarterly results
- 9 Jul · Board meeting
  CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2024 ,inter alia, to consider and approve the following business: 1. .... (opens in a new tab)
May 2024
- 27 May · Board meeting
  Outcome Of The Board Meeting Held On Monday, May 27, 2024 (opens in a new tab)
- 10 May · Board meeting
  Meeting on 27 May 2024: audited results
- 10 May · Board meeting
  CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 ,inter alia, to consider and approve the following business: 1. .... (opens in a new tab)
Jan 2024
- 29 Jan · Board meeting
  1. Approval the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2023 along with the Limited Review Report thereon. 2. Approved the .... (opens in a new tab)
- 9 Jan · Board meeting
  Meeting on 29 Jan 2024: quarterly results
- 9 Jan · Board meeting
  CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 ,inter alia, to consider and approve 1. the Un-Audited .... (opens in a new tab)
Oct 2023
- 27 Oct · Board meeting
  Approval of Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2023 along with the Limited Review Report thereon. (opens in a new tab)
- 16 Oct · Board meeting
  Meeting on 27 Oct 2023: quarterly results
- 16 Oct · Board meeting
  CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 ,inter alia, to consider and approve the Un-Audited .... (opens in a new tab)
Jul 2023
- 14 Jul · Board meeting
  Meeting on 27 Jul 2023: quarterly results
- 14 Jul · Board meeting
  CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 ,inter alia, to consider and approve 1. the Un-Audited .... (opens in a new tab)
May 2023
- 15 May · Board meeting
  Meeting on 24 May 2023: audited results
- 15 May · Board meeting
  CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 ,inter alia, to consider and approve 1. To consider .... (opens in a new tab)
Jan 2023
- 31 Jan · Board meeting
  (Listing Regulations), we wish to inform you that the Board of Directors of the .... (opens in a new tab)
- 31 Jan · Board meeting
  (Listing Regulations), we wish to inform you that the Board of Directors of the .... (opens in a new tab)

Star Source Multi Trade board meetings

Sep 2026

Aug 2026

May 2026

Feb 2026

Nov 2025

Aug 2025

Jul 2025

May 2025

Apr 2025

Jan 2025

Oct 2024

Jul 2024

May 2024

Jan 2024

Oct 2023

Jul 2023

May 2023

Jan 2023